ArticleStatistics in biopharmaceutical research2021

A comparative study of Bayesian optimal interval (BOIN) design with interval 3+3 (i3+3) design for phase I oncology dose-finding trials.

Yanhong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.